This retrospective study evaluates the role of albumin-bilirubin (ALBI) and platelet-albumin-bilirubin (PABLI) grades in predicting overall survival in high-risk patients undergoing conventional transarterial chemoembolization (cTACE) for hepatocellular carcinoma (HCC). This program is designed to meet the educational needs of interventional radiologists, hepatologists, oncologists, radiation-oncologists, hepato-biliary surgeons, nurses, techs, and trainees at all level with special interest in HCC.
The SIR Journal CME Program is a convenient way to fulfill your CME requirements while learning about the latest advances in medicine and research. Each month, one article in the Journal of Vascular and Interventional Radiology (JVIR) will have a companion CME exam. To receive CME credit for this journal-based CME activity, participants must read the journal article and score 60% or better on the exam. Participants will have three opportunities to score 60% or better.
After purchasing access to this educational activity, you will be directed to the SIR Learning Center to participate in the activity and obtain your certificate.
Describe the factors that have been reported to increase the risk of complications following cTACE.
Cite the approximate median survival in patients with ALBI grades 1, 2 and 3 respectively.
Recognize the advantage of ALBI grades over Child Pugh (CP) score in patients undergoing cTACE for HCC.
After participating in this journal-based CME activity, learners should be able to
JVIR CME Editor
Nishita Kothary, MD
Stanford University Medical Center, Stanford CA
Jan Hansmann, MD; Maximilian J Evers, BS; James T Bui, MD; Ryan P Lokken, MD, MPH; Andrew J Lipnik, MD; Ron Gaba, MD; Charles E Ray, MD, PhD - University of Illinois Hospital and Health Sciences System, Department of Radiology, Division of Interventional Radiology, Chicago, IL 60612
This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME).
The Society of Interventional Radiology (SIR) is accredited by the ACCME to provide continuing medical education for physicians. SIR designates this education activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program is approved for 1 self-assessment CME credit (SA-CME) by the Society of Interventional Radiology (SIR) - approved August 1, 2017. SIR is awarded Deemed Status by the American Board of Radiology (ABR). The SA-CME credit offered for this enduring activity meets the ABR’s criteria for self-assessment toward the purpose of fulfilling requirements in the ABR Maintenance of Certification (MOC) Program.